DGCI gives nod for phase 2/3 trials of Biological E’s Covid vaccine on those aged between 5 & 18
PTI, Sep 2, 2021, 9:34 AM IST
Credit: iStock Photo
The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its ‘Made in India’ Covid-19 vaccine on children aged between 5 and 18 years with certain conditions, sources said.
The phase 2 and 3 clinical trials have be conducted as per approved protocol titled ‘A Prospective, Randomised, Double-blind, Placebo controlled, Phase-2/3 Study to Evaluate Safety, Reactogenicity, Tolerability and Immunogenicity of Corbevax Vaccine in Children and Adolescents’, a source said.
The trial will be conducted across 10 sites in the country.
The DCGI’s permission was given based on the recommendations by the Subject Expert Committee (SEC) on Covid-19.
So far, indigenously developed Zydus Cadila’s needle-free Covid-19 vaccine ZyCoV-D has received Emergency Use Authorisation from the drug regulator, making it the first vaccine to be administered in the age group of 12-18 years in the country.
Meanwhile, the data of phase 2/3 clinical trials of Bharat Biotech’s Covaxin in the age group 2 to 18 years is underway.
India’s drug regulator in July granted permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions.
Biological E’s anti-coronavirus shot, Corbevax, which is a RBD protein sub-unit vaccine is currently undergoing phase 2/3 clinical trials on adults, sources had said earlier.
Biological E will supply 30 crore doses of Corbevax to the central government by December, as announced by the Union Health Ministry in June. The ministry finalised arrangements with the Hyderabad-based vaccine manufacturer to reserve 30 crore vaccine doses, an official statement had said.
The Biological E Covid-19 vaccine candidate has been supported by Government of India from preclinical stage to phase 3 studies. The Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 crore but has also partnered with Biological E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad, a Health Ministry statement had stated.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Religious harmony threatened by Congress and supporters, claims Adityanath
Lok Sabha Polls 2024: Congress suspends Surat candidate Kumbhani, whose nomination form was rejected
Sibal criticizes EC for not issuing notice to Modi, terms it ‘powerless entity’
SC verdict on EVM a vindication of our faith in institutions: PM Modi in Bihar rallies
Shah: UCC Implementation in MP Fulfills BJP Pledge, Modi’s Commitment
MUST WATCH
Latest Additions
Stars of Kannada film industry descend to cast votes for LS polls
China says talks on Tibet only with Dalai Lama’s representatives; rules out dialogue on autonomy
Religious harmony threatened by Congress and supporters, claims Adityanath
Lok Sabha Polls 2024: Congress suspends Surat candidate Kumbhani, whose nomination form was rejected
Sibal criticizes EC for not issuing notice to Modi, terms it ‘powerless entity’